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Abstract
We propose a new mathematical model to learn capillary leakage coefficients from
dynamic susceptibility contrast MRI data. To this end, we derive an embedded
mixed-dimension flow and transport model for brain tissue perfusion on a sub-voxel
scale. This model is used to obtain the contrast agent concentration distribution in
a single MRI voxel during a perfusion MRI sequence. We further present a mag-
netic resonance signal model for the considered sequence including a model for local
susceptibility effects. This allows modeling MR signal–time curves that can be com-
pared to clinicalMRI data. The proposedmodel can be used as a forwardmodel in the
inverse modeling problem of inferring model parameters such as the diffusive capil-
lary wall conductivity. Acute multiple sclerosis lesions are associated with a breach
in the integrity of the blood brain barrier. Applying the model to perfusion MR data
of a patient with acute multiple sclerosis lesions, we conclude that diffusive capil-
lary wall conductivity is a good indicator for characterizing activity of lesions, even
if other patient-specific model parameters are not well-known.
KEYWORDS:
brain tissue perfusion; multiple sclerosis; microcirculation; embedded mixed-dimension; NMR signal
modeling
1 INTRODUCTION
Multiple sclerosis (MS) is characterized by a cascade of inflammatory reactions that result in the formation of acute demyeli-
nating lesions (MS plaques). Acute lesions are associated with an impaired blood-brain-barrier (BBB)1. In healthy brain tissue,
the tight junctions between endothelial cells forming the blood vessel walls, are an efficient barrier for most molecules in the
brain capillaries. In active MS lesions tight junctions have been found to be damaged or open2. Due to an auto-immune reaction,
immunological cells can pass the BBB and attack the myelin sheath covering the electrical pulse conducting axons, leading to
dysfunctions of the central nervous system3. Magnetic resonance (MR) enhancement, using contrast agents such as Gadolinium-
based molecules, corresponds to areas of inflammation and contrast agent leakage into the extra-vascular space. Furthermore, it
is related to the histologic age of the plaques4. Advanced imaging techniques, such as perfusion MR imaging (perfusion MRI),
aim at the characterization of the temporal evolution of enhancing lesion formation in relapsing-remitting MS5. Perfusion MRI
0Abbreviations:MR, magnetic resonance; MRI, MR imaging
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is sensitive to inflammatory activity and can depict active lesions previous to Gadolinium enhancement and even after its disap-
pearance6. Furthermore, it has been shown that perfusion in lesions is highly dynamic and related to the activity and temporal
evolution of the lesions7,8. Cross-sectional studies in normal appearing white matter (NAWM) have also demonstrated abnormal
perfusion behavior in patients with MS compared with healthy controls (for review, see9).
Dynamic susceptibility contrast MRI (DSC-MRI) has proven to be informative when assessing the integrity of the blood-brain
barrier (BBB)10,11. In a typical DSC-MRI study, contrast agent is administered intravenously (bolus injection) and whole brain
MR image sequences are recorded with a repetition time of about two seconds over a few minutes11. Normal appearing white
matter is distinguished from inflammatory plaques by image contrast and differences in intensity–time curves. Using adequate
post-processing techniques, qualitative assessment of leakage coefficients allows to identify contrast-enhancing lesions in an
automated way12. Although today, perfusion MRI is not considered a standard procedure in the neuro-imaging workup of MS,
it enables a classification of lesions according to parenchymal leakage of an MR contrast agent due to differences in perfusion
behavior13. Perfusion imaging, both DSC and dynamic contrast enhanced (DCE), may provide information about the leakiness
of the tissue under investigation. In this work, we investigate DSC-MRI. However, the extension of the method to DCE-MRI is
conceivable.
For the interpretation of images obtained in a DSC-MRI study, the gray scale image sequence is post-processed to provide
indicators within regions of interest to the radiologist. Two typical signal intensity–time curves from the brain white matter, with
the characteristic first pass signal dip, are shown in Figure 1. Mathematical models (forward model) for contrast agent perfusion
in the brain tissue can help understanding the underlying reasons for a particular intensity–time curve of a voxel, by identifying
and analyzing the model parameters which are able to reproduce the MRI data. This process is also known as solving the inverse
problem. To this end, the model parameters are tuned by using parameter estimation techniques. Forward models are typically
based on a two-compartment pharmacokinetic tracer model and are parameterized by a small number of parameters14,15,16.
Figure 2 visualizes a two-compartment model conceptually, with compartments representing plasma and extra-vascular, extra-
cellular space. The plasma compartment is supplied by a flux determined by an arterial input function (AIF)17. The AIF can be
estimated from voxels that are mostly constrained within a larger afferent artery18. The plasma compartment exchanges mass
with the extra-vascular, extra-cellular space proportionally to its permeability-surface product. Common indicators derived from
such models are the cerebral blood volume (CBV), the cerebral blood flow (CBF), the mean transit time (MTT), and leakage
coefficients19,12,10.
A routinely used state-of-the-art post-processing procedure and model is described in12. Such models have to reflect two
processes: (1) the perfusion process governed mainly by bio-fluid-mechanical principles, and (2) the physical process of nuclear
magnetic resonance (NMR) exploited to acquire the MR image. There have been many suggestions for improving the modeling
FIGURE 1 Signal intensity–time curves in a contrast-enhancing lesion (red) and in NAWM (blue) with the respective sampling
locations in the brain (left). Signal values are normalized to the pre-contrast baseline. Data obtained by gradient echo - echo
planar imaging (GRE-EPI), at magnetic field strength 3 T, repetition time TR = 1400ms, echo time TE = 29ms, flip angle

















FIGURE 2 Schematic figure of a two-compartment pharmacokinetic model for tissue perfusion. Concentrations are denoted by
C(t), where the subscript a stands for aterial, p for plasma, and e for extra-vascular, extra-cellular space, Fp is the plasma flux,
and PS denotes the permeability-surface product, a proportionality constant of the transmural exchange rate.
of the latter process20,21,22,23. The authors of24,25 show that the local, sub-voxel tissue structure has a significant effect on the
NMR signal. However, all previous studies, including the recent study by23, rely on state-of-the-art two-compartment models
for the perfusion process providing only average concentrations in two tissue compartments within a voxel.
To overcome the limitations of two-compartment models, we present a perfusion model on a sub-voxel scale, including the
capillary network structure. Fully, three-dimensionally resolved fluid-mechanical models of brain tissue perfusion imply pro-
hibitively complex and computationally expensive simulations due to the large number of vessels, their non-trivial geometrical
embedding, and the complex geometry of the extra-vascular, extra-cellular space26. To reduce complexity, we use a mixed-
dimension embedded model description, where blood vessels are represented by a network of cylindrical segments which are
embedded into the extra-vascular space, represented by a homogenized three-dimensional continuum. The model reduction,
which is described in more detail in the following, leads to a coupled system of one-dimensional partial differential equations for
flow and transport in the vessels, and three-dimensional partial differential equations for flow and transport in the extra-vascular
space. Related models have been used to study the proliferation of cancer drugs27,28,29, the transport of oxygen30,31,32,33,34, and
nano-particle transport for hypothermia therapy35. A recent study36 describes contrast agent perfusion based on diffusive trans-
port with a mixed-dimension model. The herein presented fluid-mechanical model is similar to the drug proliferation model
described in27,37 and introduced in28. It is derived here for the specific application of contrast agent perfusion in brain tissue.
The mathematical background of such models is analyzed in several works28,38,39,40,41,42.
The fluid-mechanical model is coupled to an NMR signal model. We propose that the local distribution of the contrast agent
and resulting local susceptibility effects obtained by a sub-voxel scale model may better explain the NMR signal response of the
tissue. The application of this new perfusion model is demonstrated for the example of MS lesions.
In the following, we refer to the sub-voxel spatial scale, ranging from a few micrometers to several hundreds of micrometers,
as meso-scale. We call the scale below the meso-scale, which includes the molecular scale, micro-scale, and refer to the scale
above as macro-scale.
2 MIXED-DIMENSION EMBEDDED MODEL FOR BRAIN TISSUE PERFUSION
The tissue is conceptually decomposed into two domains. The vascular compartment comprises blood vessels, including the
capillary lumen, the endothelial surface layer, the basement membrane, and blood. The extra-vascular compartment includes
cells, the extra-cellular matrix (ECM), and the interstitial fluid. The compartments communicate by the exchange of fluids
and molecules over the capillary wall (transmural exchange). In the following three sections, the assumptions are discussed
separately for both compartments and the transmural exchange. These sub-domain models are then combined, to obtain the
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2.1 Vascular compartment
Blood flow can generally be described by the Navier-Stokes equations. Assuming negligible radial velocities, long vessels
(compared to their radius), low Reynolds numbers (Re ≪ 1), non-pulsatile flow, and rigid vessel walls, the equations can be
simplified to a one-dimensional description by averaging over cross-sections43. To this end, we describe each vessel segment
by a parametrization of its center-line with the local variable s ∈ [0, 1] and the cross-section area Av ∶= Av(s). We further
introduce the effective vessel radius rv, such thatAv(s) = rv2(s), and a local cylindrical coordinate system with radial, angular,
and axial coordinates r, , z, respectively. We employ a homogenized continuum model for blood, using an apparent viscosity,
B . Assuming a constant hematocrit of 45%, the apparent viscosity can be described as a function of the effective vessel radius
by an empirical relation44, derived from experimental data,













Blood density is assumed constant, B = 1050 kgm−3 45. Under these assumptions, the flow in the lumen of a capillary vessel
















with the mean velocity vv, the rate of mass exchange with the extra-vascular compartment, q̂m, in kg s−1m, the cross-section-
averaged pressure pv.
The transport of contrast agent can be described by an advection-diffusion equation. By integration of the three-dimensional












= q̂c , (3)


















f (r)r drd = 1 for f ∈ {, }, (4)
where (r), (r) are the dimensionless velocity profile and the dimensionless concentration profile, respectively. As it has been
observed that small nano particles are likely to be distributed evenly46, we choose ! = 1.
In the following, we consider the Gadolinium-based contrast agent Gadobutrol. For the perfusion MRI sequence, it is admin-
istered intravenously in solution, with a concentration of 1mol l−1. Gadobutrol has the chemical formula C18H31GdN4O9,
corresponding to a molar mass ofM c = 604.715 gmol−1 47. In high concentrations, Gadobutrol has a significant influence on
fluid density and viscosity. However, the concentrations arriving in the brain tissue sample are strongly diluted by diffusion and
dispersion along the tortuous path through the vascular network, so that the influence on blood density and viscosity can be
neglected in this study. The binary diffusion coefficient of Gadobutrol in plasma can be estimated bymeans of the Stokes-Einstein




≈ 1.9 ⋅ 10−10m2 s−1, (5)
where P = 1.32 Pa s49 denotes the blood plasma viscosity, T the temperature in K, and kB the Boltzmann constant.
At bifurcations in the vessel network, where the equations for each segment must be coupled, we enforce conservation of
mass and the continuity of fluid pressure and contrast agent concentration.
2.2 Extra-vascular compartment
The extra-vascular compartment is modeled as a porous medium with a rigid solid skeleton, consisting of cells, fibers, and












where I , I are density and viscosity of the interstitial fluid, vt the filter velocity vector,K the intrinsic permeability tensor of the
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5
and viscosity, I = 1030 kgm−3, I = 1.32 Pa s, given that contrast agent concentrations in the extra-vascular compartment are
even smaller than in the blood stream, and we consider perfusion an isothermal process. Furthermore, we choose an isotropic








= qc , (7)
where  denotes the porosity, the ratio of pore volume to total volume in a representative elementary volume,De is the effective
diffusion coefficient, and qc (kg s−1m3) is the contrast agent mass exchange with the vascular compartment. We assume that the
interstitial space in the extracellular matrix, with pore throat diameters of around 50 nm26, still allows for a viscous flow regime.
Furthermore, it is assumed that Gadobutrol will not enter cells. The effective diffusion coefficient in the porous medium can be
estimated as De = DcI , where  denotes the tortuosity of the extra-cellular matrix, and DcI the binary diffusion coefficient ofcontrast agent in interstitial fluid, for which we choose the same value as for the binary diffusion coefficient of contrast agent
in plasma Eq. (5). Following the literature for tortuosity and porosity values26, we choose  = 0.4 and  = 0.2, which yields,
De ≈ 1.5 ⋅ 10−11m2 s−1.
2.3 Transmural exchange
The wall of continuous capillaries consists of an endothelial surface layer, a basal membrane, and a layer of charged proteins,
called glycocalyx52. Mass exchange can occur passively through the endothelial tight junctions, or through trans-cellular path-
ways. Here, we consider only transport by advection and diffusion, following45. Given a blood vessel volume fraction of 3%,
an average thickness of the endothelial surface layer of 1 µm53, and an average vessel radius of 10 µm, the volume fraction of
the capillary wall is less than 1% of the tissue volume. The capillary wall can be conceptually reduced to a two-dimensional
interface, denoted by Γ, separating the vascular from the extra-vascular compartment. Note that this results in a pressure jump
across Γ, which is inversely proportional to wall permeability and wall thickness. According to Starling’s hypothesis54,55, the




(pv − p̄t) − (v − ̄t)
]
, (8)








is the average hydraulic pressure on the vessel wall27, v, ̄t, denote the osmotic pressure in capillary lumen and interstitial space
(averaged over the vessel surface analogous to Eq. (9)), respectively, and 0 ≤  ≤ 1 is the osmotic reflection coefficient. The
difference in osmotic pressure results from large plasma proteins in the blood stream, such as albumin, and effectively draws fluid
into the vessels. For the in silico experiments, we assume the osmotic pressures to be constant, with Δ = v − ̄t = 2633 Pa56.
Furthermore, we choose  = 1. For the vascular domain, the hydraulic and osmotic pressures averaged for each cross-section on
the vessel wall coincide with the cross-section-averaged value defined on the vessel center-line for the reduced vessel model27.
Hence, we omit the average operator.
The contrast agent is assumed to be transported by advection with the plasma, as well as by molecular diffusion. The reduction
of the vessel wall to a surface leads to a concentration jump across the vessel wall, which is inversely proportional to diffusive
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is the average contrast agent mole fraction on the vessel wall,
cup =
{
cv if q̂m < 0
c̄t if q̂m > 0
(12)
denotes the mole fraction in upwind direction, and 0 ≤ c ≤ 1 denotes the solvent-drag reflection coefficient. As the considered
contrast agent is a small molecule and the endothelial tight junctions are damaged in lesion tissue, we set c = 0, neglecting
reflection. Determining D! from MRI data is the major objective of this work.
The mass balance Eqs. (2), (3), (6) and (7) are coupled by Eqs. (8) and (10), whereas Eqs. (6) and (7) are described in the
three-dimensional extra-vascular domain Ω, while Eqs. (2) and (3) are associated with the one-dimensional vascular domain
Λ. We follow the concept suggested in28: if the source terms, q̂m, q̂c , are defined as line sources along the vessel center line in
the three-dimensional domain, while the three-dimensional quantities, pt, ct, are evaluated as the average values on Γ, then, the
resulting exchange term is a good approximation of the source term in a non-reduced three-dimensional setting. To this end, we
define qm, the source term in Eq. (6), as
qm = −q̂mΛ, with ∫
Ω
f (x)Λ dx = ∫
Λ
f (x) ds ∀f (x), ∫
Ω
Λ dx = 1, (13)
so that qm is a line source restricted by the Dirac delta function Λ to the center line of a vessel. Analogously, we set qc = −q̂cΛ,
for the source term in Eq. (7).
2.4 Vessel geometry, boundary conditions and initial conditions
FIGURE 3 The capillary network grid extracted from measurements in the rat cortex57,34 and the Cartesian computational grid
for the extra-vascular domain, used for the model analysis in this study. The tubes are scaled with the respective vessel radius.
The color visualizes hydraulic pressure from high (red) to low (blue). The cones indicate the flow direction.
We base our vascular model on a small network of capillaries from the superficial cortex of the rat57,34, which we consider a
sufficient approximation of the actual capillary network geometry for type of model analysis presented in this work. The network
has the dimensions 150 µm × 160 µm × 140 µm, and is shown in Fig. 3. The location of inflow and outflow boundaries are
given in this data set. For the inflow boundaries,34 provide velocity estimates based on the vessel radius, which are applied as
Neumann boundary conditions. The inflow velocities range from 0.5mm s−1 to 3.5mm s−1, depending on the vessel radius. At
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7
grid including vascular morphology, segment radii and segment velocity estimates are given in S3 (Supporting Information).
The vessel radii are constant for each segment defined in the grid but vary from segment to segment.
The domain initially contains no contrast agent. During the perfusion MR study, 10ml contrast agent (0.1mmol per kg body
weight) is administered intravenously as a solution at 5ml s−1 and a concentration of 1mol l−1. The injected fluid thus forms
a sharp bolus. However, the bolus disperses significantly before it reaches the brain capillaries. Therefore, the concentration
inflow profile to the capillary network has to be estimated from the parameters of the bolus injection. To this end, we use an
ansatz from22






which describes a concentration profile starting at cv,in(0) = 0molm−3 and approaching an equilibrium concentration b
(molm−3, contrast agent is equally distributed in the whole body blood volume), with a single peak after the arrival of the bolus.
The parameters a (mol sm−3) and tp (s) are shape parameters of the capillary input function, and can be interpreted as the scal-
ing parameter for the area under the curve, and the time to peak, respectively, in the absence of re-circulation (b = 0). The
parameter values are patient-specific and also depend on the location in the brain. Values for a,b, and tp are discussed below, in
the context of parameter estimation.
At the inflow boundary, contrast agent influx is enforced by a Neumann boundary condition. At the outflow boundary, the
normal mole fraction gradient is set to zero and the advective component flux is computed by a first-order upwind scheme. For
the extra-cellular compartment, we enforce symmetry boundary conditions everywhere, assuming that the modeled domain is
surrounded by domains with similar properties.
2.5 Mixed-dimension embedded model for tissue perfusion
In summary, the complete coupled fluid mechanical model of tissue perfusion reads as:

















= −q̂mΛ in Ω, (15)
q̂m = ILpSv
[
(pv − p̄t) − (v − t)
]
,




























subject to the Neumann and Dirichlet boundary conditions on the inflow and outflow boundaries of the vascular compartment,
)Λ, respectively, and no-flow boundaries for the boundaries of the extra-vascular domain, )Ω, as discussed in the previous
section.
This model stands in contrast to the often employed two-compartment kinetic modeling approaches, because it resolves
meso-scale flow phenomena, and because it is based on parameters with a clear physical interpretation.
3 NMR SIGNAL MODEL
A model linking concentration fields with the nuclear magnetic resonance (NMR) signal response is required to connect the
results of the fluid mechanical model to clinical MRI data. To this end, we develop a model of NMR on the meso-scale. In
the following, we describe a gradient echo, echo planar sequence (GRE-EPI) commonly used in DSC-MRI. This fast imaging
technique allows acquisition of an entire brain image stack in less than two seconds. Thus, after the injection of a contrast agent,
a time series of such images can be acquired, where the characteristic signal-time curve for every voxel is dependent on the
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The GRE-EPI sequence starts with a radio frequency (RF) pulse, which reorients the magnetic moments in the tissue sample,
with the flip angle  to the main magnetic field B0. The RF pulse causes the magnetic moments to precess. Energy dissipation,







e−TE∕T ∗2 ⋅ sin()
1 − e−TR∕T1 ⋅ cos()
, (17)
where the repetition time, TR, is the time between two RF pulses, and the effective echo time, TE, is the time between RF pulse
and signal readout. The base signalS0 > 0 depends, i.a., on tissue proton density and theMR scanner hardware. In the following,
we look only at the normalized signal Sn(t) = S(t)S−1pre, where Spre is the signal before the contrast agent bolus arrives in thetissue sample. The pre-contrast signal, Spre, contains all constant factors in Eq. (17), including S0. It follows from Eq. (17) that
a shortening of T ∗2 results in a decrease of NMR signal strength, while a shortening of T1 results in signal enhancement.The following two sections introduce the models for the relaxation rates R1(cv, ct) = T −11 (cv, ct), R∗2(cv, ct) = T ∗−12 (cv, ct)which are both functions of the contrast agent concentrations cv and ct computed by the fluid-mechanical model presented
in Section 2. The authors of23 developed amodel including an artificial microstructure using a combination of a finite perturbator
method21 and a finite-difference solution of the Bloch-Torrey equations. However, their model is coupled to a two-compartment
tracer perfusion model, only providing voxel-averaged concentrations. In contrast, the presented perfusion model computes the
sub-voxel distribution of the contrast agent concentration. We follow22, to develop a model considering the spatial and temporal
distribution of the contrast agent.
3.1 Transversal relaxation in tissues with locally heterogeneous microstructure
The transversal relaxation rate, R∗2, depends on the complex local microstructure of the tissue24 and is altered by the presenceof the contrast agent. We are only interested in the signal change relative to the baseline, so we split the relaxation rate in a static
pre-contrast contribution and a time-dependent contribution depending on the contrast agent concentration,
R∗2 = R̂∗2 + R∗2,pre. (18)
The relaxation rate for a sub-voxel control volume can be described by contributions of three compartments, the vascular com-
partment (v), the extra-cellular, extra-vascular space (t), and the cellular compartment (s), weighted by their volume fractions,
v, t, s 22,
R∗2 = vR∗2,v + tR∗2,t + sR∗2,s. (19)
According to25, the rate in each compartment  ∈ {v, t, s}, comprises contributions on three spatial scales
R∗2, = R∗2,,micro + R∗2,,meso + R∗2,,macro. (20)
The rate R∗2,macro describes effects of static local inhomogeneities of the magnetic fieldB0, which are time-independent. Since thestatic effects do not depend on the contrast agent concentration, they are included in the pre-contrast relaxation rate, R∗2,pre. Therate R∗2,,micro depends on the local chemical composition. The effects are independent of the pulse sequence. Gadolinium-basedcontrast agent molecules increase the relaxation rate, which can be described by a linear relationship25,
R∗2,,micro = r2c + R∗2,,pre,micro, (21)
where r2 is the molar relaxivity, and c the local molar contrast agent concentration in compartment . The molar T2 relaxivity,
r2, of Gadobutrol at 3 T and 37 ◦C is approximately 3.9m3mol−1 s58. Here, we assume that the contrast agent cannot enter the
cells, cs = 0, hence R∗2,s,micro = 0.The term R∗2,meso stems from a meso-scale effect. The magnetic field perturbations induced by the difference in magneticsusceptibility in the blood vessel and the extra-vascular space, increase the relaxation rate of the extra-vascular space in proximity
of a blood vessel. The generated magnetic field perturbations are several orders of magnitude smaller than B0. Furthermore, the
influence decays rapidly with distance to the vessel surface. Therefore, we consider each segment of the vessel network to cause
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where |c̃v − c̃t| is the difference of the average vessel surface concentrations, given by the average over the entire vessel surface
contained in this sample. The factor B ≥ 0 is an ad-hoc parameter, scaling the strength of these perturbations. The propor-
tionality factor 'i models the decay of the influence of the with distance from the vessel wall. We set 'i = rv2∕r2, assuming
a quadratic decay, where r is the distance to the vessel center line and rv the radius of the vessel segment. The susceptibility
contrast likewise increases the transversal relaxation rate, which we model by
R∗2,meso,v = B|c̃v − c̃t|. (23)
The same effect occurs at the cell surfaces, induced by the difference in magnetic susceptibility between interstitial space and





'i|c̃v − c̃t|i + T |c̃t,s|, (24)
and to the relaxation rate of the cell compartment,
R∗2,meso,s = T |c̃t,s|, (25)
where T ≥ 0 is a second ad-hoc parameter, determining the strength of these perturbations, and c̃t,s is the average molar
concentration on all cell surfaces contained in a tissue sample. Furthermore, we assume that there is no direct interface between
the cells and the vascular compartment.
Combining Eqs. (19), (21) and (23) to (25), we obtain a formulation for the transversal relaxation rate dependent on the
concentration fields and the volume fractions of the three compartments:





'i|c̃v − c̃t|i + T |c̃t,s|)
+ s(T |c̃t,s|). (26)
3.2 Longitudinal relaxation with contrast agent administration
Similar to T ∗2 , the contrast agent also shortens T1. However, the effects occur merely on the micro-scale. Thus, we can modelthe relaxation rate R1 = 1∕T1 of the tissue sample by
R1 = r1(vcv + tct) + R1,pre, (27)
where we implicitly assumed that contrast agent does not enter cells, cs(x, t) = 0. The molar T1 relaxivity, r1, of Gadobutrol at
3 T and 37 ◦C is approximately 3.2m3mol−1 s58.
3.3 Voxel signal
The relaxation rates, R∗2 and R1, Eqs. (26) and (27), are computed for each control volume (cell) in the three-dimensional domain
Ω. The volume fraction of the vascular domain, v, is computed by integrating over the volume of all vessels within a control
volume and dividing this number by the volume of the control volume. The average values c̃t,s and c̃t are approximated by the
discrete cell values. The average c̃v is computed by intersecting the vessel center-line mesh with the mesh discretizing Ω and
attributing the surface of the intersecting vessels to the intersected control volume. A local NMR signal can then be computed
for each control volume by using Eq. (17). The voxel signal is determined by the volume average of all control volume signals.
To this end, we assume that the size of our domain is large enough to be representative for an entire voxel, which is commonly
about 10 to 20 times larger in diameter than the given domain.
4 NUMERICAL TREATMENT AND IMPLEMENTATION
The equations of the fluid flow equation system, Eq. (15), and the contrast agent transport system, Eq. (16), are discretized with a
cell-centered finite volume method with a two-point flux approximation in space, and an implicit Euler method in time. The two
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can be solved independently of Eq. (16). Furthermore, Eq. (15) is stationary, so that the pressure field only has to be computed


















, u ∈ {p, x}, (28)
where u is the respective discrete primary variable (fluid pressure in Eq. (15), contrast agent mole fraction in Eq. (16)), and
Δu denotes the difference of the current solution to the solution of the previous time step (or to the initial guess for stationary
problems). The Jacobian matrix J u can be split into blocks, whereAuv is the block with derivatives of the residual ruv with respectto the degrees of freedom uv of the discrete vascular domain Λℎ ⊆ Λ, Cuv→t contains derivatives of the residual ruv with respectto the degrees of freedom ut of the discrete extra-vascular domain Ωℎ ⊆ Ω, and Aut , Cut→v are defined analogously in terms ofthe residual rut .The linear equation systems, Eq. (28), are solved using a left preconditioned stabilized bi-conjugate gradient method59






where ILU0(A) denotes an incomplete LU-factorization of the matrix A using A’s sparsity pattern (zero fill-in)59 Chapter 10.
We assume that the influence of the sub-voxel contrast agent evolution during a single image acquisition on the NMR signal
is negligible, and thus, Eq. (17) is solved as a post-processing step after each time step of the perfusion model.
The model converges in time and space to a reference solution computed on a very fine grid and a very small time step size.
The convergence study is described in detail in S1 (Supporting Information). As a result of the convergence study, we choose
our computational grids such that the largest grid cell does not exceed 8 µm. This results in a run-time of a few seconds on a
normal laptop for a single forward model run.
The model is implemented with the open-source porous media simulator DuMux 60, which is based on the Distributed Unified
Numeric Environment (DUNE)61,62. The implementation of the mixed-dimension embedded tissue perfusion model is based
on a recent extension of DuMux for multi-domain porous media problems, first described in63 for the simulation of root–soil
interaction in the vadose zone. We refer to this publication for a more detailed description of the discretization, assembly proce-
dure, and software implementation of mixed-dimension embedded models. The source code used for all numerical experiments
in this work is publicly available at https://git.iws.uni-stuttgart.de/dumux-pub/Koch2019a.
5 INVERSE MODELING USING CLINICAL MRI DATA
We use clinical MRI data to evaluate the presented model. We choose a patient with relapsing-remittingMS from a clinical study
with 12 MS patients, diagnosed according to the revised McDonald’s criteria64, and showing at least one contrast enhancing
lesion on MRI. The data is selected from a previous study that has been published elsewhere65, and fully anonymized for further
analysis. For the employed GRE-EPI protocol, 19 parallel images with a slice thickness of 5mm are taken 80 times during
an acquisition time of 119 s. The sequence parameters are given in the caption of Fig. 1. From these images, a clinical expert
annotated a voxel within a Gadolinium enhancingMS lesion (sample L) and a corresponding voxel in NAWM (sample N). Fig. 1
shows the samples L and N, together with the respective voxel locations in the MRI slice.
Several model parameters can be assigned a fixed value, either because the parameter assumes a well-known fixed value
given in the literature, or because the parameter is not expected to significantly affect the results of this particular study and an
approximate value can be obtained from the literature. However, there are also parameters that are inherently patient-specific
and cannot be directly measured, or parameters for which the measurement data is not available for the given patient. These
parameters are, a, b, tp, B , T , T1,pre, T ∗2,pre, Lp, D!. Determining these parameters for a given signal–time curve constitutes aninverse problem. In particular, we aim to determineD!, which may quantify contrast agent leakage, and thus, has direct clinical
relevance.
In the following, we briefly discuss typical values or value ranges for these parameters. The shape parameters, a, b, tp, deter-
mine the inflow profile of the bolus arriving at the voxel under study. They are generally varying from voxel to voxel. In particular,
a and tp depend on the voxel location and vessel network structure, as well as the resulting bolus dilution during transport
through the vessel tree. The equilibrium contrast agent concentration, b, depends on the patient’s blood volume. Neglecting the
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parameter Best fit (L) Best fit (N)
a 30.08mol sm−3 30.03mol sm−3
b 1.20molm−3 0.61molm−3
tp 4.75 s 6.03 s
Lp 7.20 ⋅ 10−12mPa−1 s−1 1.00 ⋅ 10−12mPa−1 s−1
D! 8.20 ⋅ 10−8ms−1 1.01 ⋅ 10−10ms−1
B 14.19 35.59
T 0.73 1.00
T1,pre 1.76 s 2.00 s
||Eopt||2 0.055 0.082
TABLE 1 Parameter values obtained by a global optimization algorithm for the best fit of model and MRI data, minimizing
||Eopt||2. The second column shows the parameters for the lesion sample (L), the last column the parameters for the NAWM
sample (N).
agent divided by the total blood volume. However, b, can become lower in regions of contrast agent leakage and is dependent
on the severity of the leakage and the size of the affected region in the brain. Here, we choose values for a, b, and tp within
large enough bounds to ensure physically meaningful inflow profiles. The parameters B and T are dimensionless scaling fac-
tors for the effect of meso-scale T ∗2 -shortening due to the magnetic susceptibility contrast at the interface of the vascular andthe extra-vascular, extra-cellular compartment and the interface of the extra-vascular, extra-cellular and the cell compartment,
respectively. Because these values depend on the tissue architecture, B and T can also mitigate errors in the NMR signal pre-
diction caused by patient-specific variations in vessel geometry. The pre-contrast relaxation times T1,pre and T ∗2,pre vary fromvoxel to voxel. From Eq. (17), it is clear that T ∗2,pre cancels when S(t) is normalized. Therefore, the value of T ∗2,pre is not criticalfor the present study. The authors of66 measured T1,pre in patients with relapsing-remitting MS for several lesion types. They
reported values between 1.9 s for black holes, and 0.8 s for NAWM, at 3 T. The filtration coefficient Lp characterizes the fluid
mass exchange between the vascular and the extra-vascular compartment. The authors of51 suggest Lp = 2.7 ⋅ 10−12mPa−1 s−1
for normal subcutaneous and Lp = 2.1 ⋅ 10−11mPa−1 s−1 for tumor tissue. While in normal brain tissue the contrast agent stays
in the blood stream, it leaves the vascular compartment over the vessel wall in regions where the BBB is impaired. Therefore,
the filtration coefficient Lp is likely to be elevated in such tissue, due to opened tight junctions. The diffusive capillary wall con-
ductivity, D!, characterizes the diffusive transport of contrast agent between the vascular and the extra-vascular compartment.
It depends, i.a., on the molecular diffusion coefficient of the contrast agent, the wall thickness, porosity and the tortuosity of the
transmural pathway.
5.1 Parameter estimation
In a preliminary model investigation, we use the parameter estimation toolbox PEST67 to find the parameter set that minimizes
the sum of squared differences, ||Eopt||22, between the simulated signal-time curve and the MRI data. For the parameter estima-tion, we employ the truncated singular value decomposition algorithm, available in PEST. The estimated parameter values for
the best fit against the curves N and L, cf. Fig. 1, as well as the corresponding ||Eopt||2, are given in Table 1.
A comparison of the simulated and measured NMR signals, Fig. 4, indicates that the model can reproduce the measured
curves well. Table 1 shows that the diffusive wall conductivity, D!, is estimated to be low for the NAWM sample (N), and high
for the lesion sample (L), with a difference of three orders of magnitude, while the other parameters are within the same order
of magnitude. To better understand the influence of the diffusive wall conductivity on the computed NMR signal, we compute
the mass of contrast agent in the extra-vascular space
mct = ∫
Ω
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FIGURE 4 Simulated normalized NMR signals compared with MRI data (see Fig. 1), using the best fit parameter estimates
given in Table 1. Left – the result for the lesion sample (L), right – the result for the NAWM sample (N).
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FIGURE 5 The mass of contrast agent in the extra-vascular space at tend = 112 s for different wall diffusivities. The left axis
shows the contrast agent mass in the extra-vascular space, mct . The right axis shows the ratio of mct to the total injected contrastagent mass minj in percent.
at the end of the simulation, tend = 112 s. Additionally, we compute the total mass of contrast agent going into the domain over









The results are shown in Fig. 5 for different wall diffusivities. The other parameters were chosen as in Table 1, sample L. It
can be seen that for D! < 1.0 ⋅ 10−9ms−1, there is almost no leakage into the extra-vascular space, i.e. the BBB is intact. For
D! > 3.0 ⋅ 10−6ms−1, the leakage of contrast agent into the extra-vascular space has reached a plateau and does not increase
further with D!. For such high wall diffusivities, the contrast agent mole fractions in vascular and extra-vascular space reach
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which is not observed in any of the clinical data. Therefore, such high values of D! are unlikely to be physiologically sensible.
For the values ofD! in Table 1, this means that there is little to no contrast agent leakage for sample N, while there is significant
leakage for sample L. This is in accordance with the present understanding of the pathology, which assumes leaky vessel walls
in MS lesions.
However, the problem of finding best fit parameters is typically ill-conditioned, or even ill-posed as the solution may be non-
unique, such that the employed parameter estimation method may not be reliably applied. Therefore, we discuss other methods
to further analyze the model parameters in the subsequent sections.
5.2 Parameter sensitivity
For a better understanding of the influence of the patient-specific parameters on the signal–time curve, as well as the sensitivity
of the model output to the model input parameters, we perform a simple sensitivity analysis, where parameters are individually
varied, while all other parameters are kept constant at the values listed in Table 1. The results of this study are shown in Fig. 6
for sample L, and in Fig. 7 for sample N. It can be seen that the parameter sensitivity is different for L and N (which correspond
to different locations in the parameter space). Such behavior characterizes non-linear model response.
Capillary input function
The shape parameters a and tp of the capillary input function have a strong influence on the first pass dip of the NMR signal. The
influence is directly related to the T ∗2 -shortening caused by the contrast agent in the blood vessels. Comparing the respectivecurves in Fig. 6 and 7, shows that contrast agent leakage dampens the influence of a and tp. The difference in concentration
between the vascular and extra-vascular space decreases in the presence of leakage, attenuating the T ∗2 -shortening meso-scaleeffects. For sample L, a also influences the signal in later times in the presence of leakage. A higher a indicates a larger contrast
agent bolus, which will also result in a higher amount of leakage leading to a signal increase at later times, due to the T1-
shortening effect of the contrast agent in the extra-vascular space. In the absence of leakage (sample N), the late signal is only
affected significantly by the equilibrium concentration b. For sample L, b has a significant influence on the late signal slope. In
that case, the signal slope is directly related to the leakage rate. With a higher b, the gradient of the contrast agent concentration
over the vessel wall is higher, leading to a higher leakage rate. For b = 0, the slope is negative, indicating that leaked contrast
agent flows back into the vascular compartment.
NMR parameters
The NMR parameters, B , T , T1,pre, have an equally strong but different effect on the NMR signal. The scaling parameter B
for the meso-scale T ∗2 -effects from the vascular wall, affects the signal strength almost linearly throughout the entire simulation.For B = 0, i.e. if meso-scale effects on T ∗2 -relaxation are neglected, the early time signal enhancement due to T1-shorteningbecomes even stronger than the signal decrease due to T ∗2 -shortening, as clearly seen in Fig. 7. This illustrates that it is essentialfor the NMR signal model to include meso-scale effects. The scaling parameter T for the meso-scale T ∗2 -effects from the cellwalls, only influences the signal in the presence of leakage (sample L). This is evident, since the difference between the contrast
agent concentration in the cells and the extra-vascular, extra-cellular compartment is zero, in the absence of leakage. Fig. 6 shows
that signal decrease due to T ∗2 -shortening in the extra-vascular compartment exceeds signal enhancement due to T1-shortening,if T is chosen too large. Because this is not seen in any of the clinical data, T is likely to be small (T < 10). The pre-contrast
longitudinal relaxation time, T1,pre, shows a direct influence on the signal-enhancing effect of T1-shortening. If T1 is already
elevated before the administration of contrast agent, the T1-shortening has a strong signal-enhancing effect. If T1,pre is closer to
T1 values measured for NAWM66, the signal-enhancing effects are significantly weaker. Fig. 6 suggests that signal enhancement
is small if T1,pre is not elevated, even in the presence of leakage.
Leakage coefficients
The leakage coefficients for advective and diffusive transmural transport, Lp and D!, show a very similar qualitative influence
on the NMR signal. However, the sensitivity of the NMR signal with respect to changes in Lp is significantly lower than the
sensitivity with respect to changes in D!. This suggests that the main mechanism for transmural contrast agent leakage is of
diffusive nature. Furthermore, note that changing D!, while keeping the other parameters constant, can change the signal–
time curve from the shape of sample N to the shape of sample L, and vice versa. This further emphasizes that diffusive wall
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FIGURE 6 Influence of different flow, transport, andNMRparameters on the signal–time curve. The parameters are individually










This article is protected by copyright. All rights reserved.
15




















































































































































































FIGURE 7 Influence of different flow, transport, andNMRparameters on the signal–time curve. The parameters are individually
varied, while the other parameters are chosen as in Table 1 (sample N).
5.3 Bayesian parameter inference
To complete our critical assessment of the proposed model, we ask and attempt to answer the question:What can we learn about
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model, given some prior knowledge about the parameters, and observations, while quantifying the uncertainty that is inherent to
such a parameter estimation. Let  denote the parameters of the model, andX the vector of observed values. Bayes’ theorem,





where p(|X) is the posterior distribution, i.e. the probability of  given the observation data X. p(X|) is the likelihood func-
tion, i.e. the probability of theX being from the same population as the model prediction, given . p() is the prior distribution
reflecting prior knowledge about the parameters , before knowing the observations. p(X) is the marginal likelihood, a normal-
ization constant, not depending on . Now, let Y = () be the model prediction given the the parameters . We assume that
we can write





where  is the combination of measurement error and unbiased model error and  its standard deviation. The likelihood that any






if the errors of all observations are assumed to be uncorrelated. The standard deviation, , has to be estimated for the given MRI
data and the proposed model. The measurement error is estimated from the MRI data obtained before the contrast agent bolus
reaches the tissue sample, where the measurement is assumed to fluctuate around a constant baseline signal. To this end, we take
100 random signal samples from the brain slice shown in Fig. 1, normalize the signal to the mean of the first 10 sample data
points, and compute the standard deviation of all such baseline data points across all samples, yielding  = 0.009. Furthermore,
we assume that our mathematical model captures the most significant physical processes. The model error is assumed to be
sufficiently estimated using, in total, a standard deviation of  = 0.009. We are aware that this assumption may be too restrictive,
in which case the estimated model parameters may additionally include modeling uncertainties that may compromise their
physical interpretability for the underlying physical process. However, the estimated standard deviation of  = 0.009 represents
a rather large uncertainty given relative signal changes in the order of 0.1, see ??. To estimate the effect of assuming a larger
model uncertainty, we run a second numerical experiment with a 10-fold increase of the standard deviation.
Markov chain Monte Carlo (MCMC) methods are methods to sample from the posterior distribution p(|X) without the need
to compute marginal likelihood, which is generally expensive. MCMC draws samples on a random walk through the parameter
space, creating a representative set of samples from the posterior distribution, after a sufficient number of iterations. These
samples form a Markov chain such that the parameters with which the sample is generated in one step only depend on the
parameters in the previous step. Herein, we use the ensemble sampler proposed in68, which is implemented in the Pythonmodule
emcee69. Its algorithm features an ensemble of interdependent Markov chains (so called walkers), enabling multiple parallel
forward model runs within one step. For a brief description of the algorithm, see S2 (Supporting Information). We refer to the
literature68,69 for a comprehensive discussion.
In the following, Bayesian parameter inference is used to compute the probability distribution of the patient-specific model
parameters, under physical parameter constraints, given a signal–time curve from a voxel of a perfusion MRI sequence. To this
end, we choose the prior distributions of the parameters to be uniform distributions within the bounds given in Table 2. The
ensemble sampler is configured with k = 100 walkers. The parameter vector is  = [a, b, tp, log10D!, T1,pre, B , T
]T , so that
N = 7. The parameter Lp remains fixed to reduce the dimension of the parameter space. Its influence on the NMR signal has
been shown in the previous section to be significantly weaker than the influence of D! (see Fig. 6).











(fk − f )(fk+t − f ), (35)
where f = {fi}Mi=1 is a finite chain of length M , e.g. the value of parameter a for each sample in the Markov chain, and
f its arithmetic mean. We use an estimate of the integrated auto-correlation, f,e, using the Python module acor 70,71. We
compute this estimate for the chain of each parameter, i, and use the maximum and minimum values, max = max0≤i<N i,e,
min = min0≤i<N i,e. The sampler is run until the sample size, j > 100 ⋅ max, and the change in the auto-correlation timeestimate from sample j − max to sample j is less than 1%. The resulting histograms for each parameter and their covariance
with respect to the other parameters is visualized in Fig. 8 for sample L and Fig. 9 for sample N (cf. Fig. 1). The plots show the
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parameter prior distribution unit
a uniform in [0, 200] mol s l−1
b uniform in [0, 2.0] mol l−1
tp uniform in (0, 15] s
− log10D! uniform in [5, 12] m s−1
Lp fixed at 1 ⋅ 10−12 mPa−1 s−1
T1,pre uniform in [0.8, 2.0] s
B uniform in [0, 100] -
T uniform in [0, 100] -
TABLE 2 Prior distribution for parameters inferred by a Markov chain Monte Carlo method.
the burn-in phase of the MCMC algorithm, the first 10 ⋅ max samples are discarded. To have only independent samples, every
min sample of the remaining samples is chosen68, while the others are discarded. The solid black lines in Figs. 8 and 9 show
the parameter values of Table 1 that were obtained previously with PEST.
To interpret the results, we recall the original question:What can we learn about the model parameters, given the MRI data?
If the posterior distribution of a parameter is close to uniform, i.e. close to the prior distribution (see Table 2), the data did not
provide any additional information about this parameter. This is, for example, the case for a, b, and T in Fig. 9, for which the
90% credible interval is wide. In contrast, if the posterior distribution differs significantly from the prior distribution, the data
provides significant information on this parameter. This is the case for the parameters D! and T in Fig. 8, which is consistent
with the observation in Figs. 6 and 7 that the sensitivity of the NMR curve with respect to those parameters is high, such that
only a small range of values for those parameters is likely to match the model results with the clinical MRI data. Furthermore,
there seem to be correlations between several parameters. For instance, the inflow curve parameters a and b show a strong and
nonlinear correlation with MR model parameter B for both samples, L and N. For high values of a and b, which corresponds
to an increase in the amount of contrast agent entering the tissue sample, it is more likely that B is low, which decreases the
effect of contrast-induced signal reduction. Conversely, a high B is more likely if a and b are low. This effect is expected, since
high concentration values correspond to a higher signal reduction in the vascular compartment, see Eqs. (21) and (27).
Most interestingly, the distribution ofD! in Fig. 8 differs significantly from the distribution ofD! in Fig. 9. Both distributions
are shown as histograms in Fig. 10 for the experiment with  = 0.009, as well as for the experiment with an increased model and
measurement error uncertainty. For sample L, the inferred posterior distribution of the diffusive wall conductivity has a distinct
peak around D! = 9 ⋅ 10−8ms−1 (3 ⋅ 10−7ms−1 for high ). Furthermore, it shows that values below D! = 3 ⋅ 10−8ms−1 are
unlikely, suggesting significant transmural contrast agent leakage with a high probability. For sample N, the inferred diffusive
wall conductivity is likely low (< 5 ⋅ 10−9ms−1), suggesting little to no leakage; see Fig. 5. For low , the results suggest that
D! values between 3 ⋅ 10−9ms−1 and 3 ⋅ 10−8ms−1 are more likely than respective lower values. This could indicate that there
may be a small amount of contrast agent leakage in the NAWM sample. That this effect may indeed occur, is suggested in several
clinical studies8,73. However, this effect can not be seen for the numerical experiment where  is assumed 10 times higher
(Fig. 10, right). Here, all values below D! = 1 ⋅ 10−8ms−1 are equally likely. Consequently, the indication of leakage in the
given NAWM sample could also be an artifact resulting from an overconfidence in the accuracy of the measurement or model
data. Moreover, more than 50% (70% for high ) of theD! sample values fall below 3 ⋅ 10−9ms−1 (including the value obtained
with the optimization approach in the previous section), which corresponds to virtually no contrast agent leakage. Because of
the significant difference between the posterior distributions forD! in both samples (L and N), in particular the observation that
low D! are likely for sample N, while they are unlikely for sample L, we conclude that the two samples can be distinguished
just on the basis ofD!, without looking at the estimates for the other parameters. The uncertainty inD! reflects the fact that all
other parameters are uncertain as well. Consequently, the estimate of D! may be improved with additional information about
other parameters. Such information might be, for instance, a direct measurement of T1,pre, estimations of the AIF, or data from
other MR sequences of the same patient. Furthermore, knowledge that a parameter is expected to be similar in a certain region
of the brain, could enable learning from other voxel data of the same sequence. In the Bayesian framework, such information
can be included incrementally, where the posterior distributions of the previous Bayesian update are the prior distributions of
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log10D  = 7.11+0.170.22
FIGURE 8Histograms of model parameter distributions after learning fromMR voxel data from a lesion (see Fig. 1, sample L).
The assumed standard deviation for the measurement error is  = 0.009. The histograms on the diagonal are the histograms for
single parameters, the scatter plot in the matrix shows the covariance between the respective row and column parameters (plot
generated with72). The histogram titles show median, 5th and 95th percentile (visualized as dashed lines). The horizontal and
vertical solid black lines show the parameter values for sample L of Table 1.
The values estimated for D! cannot be compared to values from two-compartment models straightforwardly. These models
are formulated on the macro-scale using averaging techniques. The relation of fluid-mechanical models on the meso-scale (as
considered in this work) and models formulated on the macro-scale is yet to be better understood and is addressed in some
recent studies74,75,76,77. However, values for the diffusive wall permeabilities have been estimated from direct measurements




















































T1, pre = 1.72+0.200.37
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FIGURE 9Histograms of model parameter distributions after learning fromMR voxel data fromNAWM (see Fig. 1, sample N).
The assumed standard deviation for the measurement error is  = 0.009. The histograms on the diagonal are the histograms for
single parameters, the scatter plot in the matrix shows the covariance between the respective row and column parameters (plot
generated with72). The histogram titles show median, 5th and 95th percentile (visualized as dashed lines). The horizontal and
vertical solid black lines show the parameter values for sample N of Table 1.
aware of such measurements for Gadobutrol. Nevertheless, D! values can be assumed to be similar for molecules with similar
properties as Gadobutrol (hydrophilic,M = 604.715 gmol−1 47, rhy ≈ 0.8 nm48). For example, for sucrose (hydrophilic,M =
342.30 gmol−1, rhy ≈ 0.45 nm84) values in the order of 1.4 ⋅ 10−6ms−1 to 1.4 ⋅ 10−7ms−1 are reported for frog mesentery82 and
skeletal muscle tissue83, depending on the measurement method. For (normal) brain tissue in dogs, no significant permeability
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FIGURE 10 Histograms for Bayesian parameter inference, when learning from NAWM data or contrast-enhancing lesion data.
A low diffusion coefficient is most likely for the NAWM data, while a high diffusion coefficient is most likely for the contrast-
enhancing lesion data.
filter mechanisms and anatomy of the capillary wall are assumed to be similar in different species85. The authors of83,80 suggest
a strong dependence on molecule size, so that for the Gadobutrol molecule with twice the size of the sucrose molecule the
expected value for skeletal muscle tissue would be one order of magnitude lower than that of sucrose, see83 Fig. 1. Hence, the
D! values for the lesion sample compare to physiological values of other tissues where capillary walls are known to be more
permeable to small molecules86 than in the brain. In comparison with our estimated value for sample L, this suggests significant
leakage and a strong increase in transmural permeability in comparison with NAWM. The values for NAWM, with two orders
of magnitude lower D! values, signify impermeable capillary walls and are in good agreement with the common assumption
that the BBB is impermeable for Gadobutrol.
6 MODEL LIMITATIONS AND OUTLOOK
The current model relies on a single exemplary vessel geometry. Today, patient-specific sub-voxel vessel geometries cannot be
routinely measured. Hence, the influence of different vessel geometries on the presented results has to be investigated.
Furthermore, the used model of the inflow curve, Eq. (14), neglects re-circulation in the form of a second or third pass of the
contrast agent. In particular, the effect of the second pass of the bolus cannot be captured and might lead to more uncertainty in
the estimation of other model parameters. In a future step, the inflow curve model can be improved to include re-circulation and
to be derived from AIF measurements. Including such measurements adds information about the inflow parameters and may
thus lead to narrower estimates of other model parameters. Moreover, we used a rather simple approach for the estimation of the
model error. In future work, the model error can be more rigorously analyzed, for example, by including the standard deviation
of the error model as a random variable. In this way, Bayesian parameter inference provides an estimate for the model error
alongside the estimates of the other model parameters. This may increase the uncertainty of the provided parameter estimations.
The presented model considers processes in a sub-voxel tissue sample that is surrounded by tissue with the same properties.
However, contrast-enhancing lesions in the brain typically span over several MRI voxels, see Fig. 1. Furthermore, patterns such
as ring-like shapes have been observed for MS87, suggesting processes on a larger scale, or possible inter-voxel dependencies.
Such effects can not be included in the model in its current state, since simulation of several voxels are prohibitively expensive
due to the large number of blood vessels.
The applicability of the presented model has yet to be confirmed in a clinical environment. This would be of special relevance
for monitoring of pharmacologic effects and drug efficacy, e.g. in drugs that are targeted against immune cell trafficking. It is to
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A current drawback of the method is the computational time required to infer diffusive capillary wall conductivities and
contrast agent leakage. However, the computational cost can most likely be improved by applying model reduction techniques
and machine learning algorithms. Likewise, homogenization techniques can be used for model reduction74,75. However, such
techniques are difficult to apply, due to the hierarchical structure of the micro-circulation. For all approaches, the presented
model can be used as theoretical basis and as validation tool.
7 SUMMARY AND CONCLUSION
We presented a mixed-dimension fluid-mechanical model for contrast agent brain tissue perfusion on the sub-voxel scale.
The blood vessels are considered as a network of cylindrical tubes. The extra-vascular compartment is modeled as a porous
medium. The presented discretization results in a coupled system of partial differential equations of three-dimensional and
one-dimensional equations. The fluid-mechanical model can describe the three-dimensional evolution of the contrast agent con-
centration on the sub-voxel scale. We further proposed an NMR signal model, describing the influence of the contrast agent
on the NMR voxel signal, including meso-scale effects. A convergence study suggests that the combined model is consistent
and converges to a unique solution on grid and time step refinement. Using parameter estimation, it was shown that the model
can describe two characteristic NMR signal curves from clinical data obtained by DSC-MRI for a patient with MS lesions, and
that the estimated model parameters provide a meaningful physical interpretation. Bayesian parameter inference, with the given
model and clinical DSC-MRI data, showed that the two given NMR signal curves can be distinguished and characterized, only
on the basis of the estimated diffusive capillary wall conductivity distributions. The study suggests that the NMR signal curve,
given the model, is informative about some patient-specific model parameters, such as the diffusive capillary wall conductivity,
and less informative about others, such as the tissue’s T1 relaxation time before contrast agent administration. Furthermore, the
uncertainty of the diffusive capillary wall conductivity predictions could be quantified in the Bayesian framework. For a sample
from within an MS plaque in the brain white matter, a value of D! = 8.2 ⋅ 10−8ms−1 was estimated using optimization. This
value corresponds to significant contrast agent leakage into the extra-vascular space. With Bayesian parameter inference, we
obtained a median value of D! = 7.8 ⋅ 10−8ms−1 and an equal-tailed 90% credible interval with lower bound 4.7 ⋅ 10−8ms−1
and upper bound 1.1 ⋅ 10−7ms−1, which contains the value obtained with optimization. With a 10-fold increase of the standard
deviation of the assumed modeling and measurement error, slightly higher values for D! were estimated to be more likely, and
the uncertainty increased (median: 3.2 ⋅ 10−7ms−1; 90% credible interval: 6.3 ⋅ 10−8ms−1 to 9.1 ⋅ 10−7ms−1). However the
values are still clearly distinguishable from those estimated for a NAWM sample, where no significant leakage is observed. The
values are comparable to the diffusive wall conductivity estimated from experiments with hydrodynamically similar substances
in skeletal muscle tissue. The results agree with the observation that endothelial tight junctions are opened in MS lesions2. In
summary, the presented model constitutes a useful tool to study contrast agent perfusion on a sub-voxel scale, and may lead to
an improved understanding of the sub-voxel processes beyond the scope of this paper.
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